Carlos González-Juanatey

TL;DR: Giant cell arteritis and Polymyalgia rheumatica are relatively common diseases in the elderly due to the progressive aging of the population in Western countries.

TL;DR: The results suggest that a chronically high inflammatory response in genetically predisposed individuals promotes an increased risk of CV events and CV mortality in RA.

TL;DR: A chronic inflammatory response may promote the development of accelerated atherogenesis in patients with RA, and active treatment of the disease is required to reduce the risk of developing CV complications in individuals with RA.

TL;DR: A rapid beneficial effect of infliximab on insulin resistance and insulin sensitivity in RA patients treated periodically with this drug is confirmed and may support the longterm use of drugs that act blocking TNF-α function to reduce the mechanisms implicated in the development of atherosclerosis in patients with RA.

TL;DR: This study confirms that the magnitude and chronicity of the inflammatory response measured by CRP correlates directly with the presence of atherosclerosis in patients with RA.